Stem cell-based therapy for COVID-19

Authors: Chen, Xiaomei, Liu, Bowen, Li, Chao, Wang, Yulian, Geng, Suxia, Du, Xin, Weng, Jianyu, Lai, Peilong

Source: In International Immunopharmacology November 2023 124 Part A

Dual vortex retarder Mueller matrix ellipsometry

Authors: Gao, Chao, Wang, Fujie, Wen, Xueke, Weng, Jianyu, Cao, Xiaoyu, Lei, Bing

Source: In Optics and Lasers in Engineering July 2023 166

Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice

Authors: Chen, Xiaomei, Wang, Yulian, Huang, Xin, Geng, Suxia, Li, Chao, Zeng, Lingji, Huang, Lisi, Du, Xin, Weng, Jianyu, Lai, Peilong

Source: In International Immunopharmacology April 2023 117

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

Authors: Akova, Murat, AlAgha, Rawan, Alangaden, George, Albrecht, Svenja J, Alexander, Barbara, Al-Obaidi, Mohanad, Ambasch, German, Armestar Rodriguez, Fernando, Azap, Alpay, Baffoe-Bonnie, Anthony, Belkhir, Leila, Ben-Ami, Ronen, Boutoille, David, Cascio, Antonio, Chai, Louis YA, Chaiwarith, Romanee, Chayakulkeeree, Methee, Chen, Sharon, Chen, Yee-Chun, Chen, Yen-Hsu, Choi, Jun Yong, Choi, Young Hwa, Chotiprasitsakul, Darunee, Chung, Jin Won, Danion, François, Denis, Blandine, Diaz Santos, Emilio, Dictar, Miguel O, Diltoer, Marc, Dupont, Herve, Feng, Sizhou, Ferre Colomer, Maria Angeles, Ferrer, Ricard, Forel, Jean-Marie Fernand Roger, Fortún-Abete, Jesús, Garcia-Diaz, Julia, Girardis, Massimo, He, Fang, Hites, Maya, Ho, Mao-Wang, Honore, Patrick, Horcajada Gallego, Juan Pablo, Huang, Haihui, Huang, Po-Yen, Huang, Yong, Hussein, Osamah, Intalapaporn, Poj, Jaruratanasirikul, Sutep, Jauregui-Peredo, Luis, Johnson, Misty, Jung, Dong Sik, Jutivorakool, Kamonwan, Kern, Winfried V, Kett, Daniel H, Khawcharoenporn, Thana, Kim, Young Keun, Koehler, Philipp, Kotanidou, Anastasia, Lachiewicz, Anne, Lin, Qinhan, Lopez Cortes, Luis Eduardo, Luo, Hong, Luzzati, Roberto, Maor, Yasmin, McCarty, Todd, Merelli, Maria, Merino Amador, Paloma, Midturi, John, Migliorino, Guglielmo Marco, Mira, Jean-Paul, Mootsikapun, Piroon, Morrissey, Orla, Munoz Garcia de Paredes, Patricia, Mussini, Cristina, Mylonakis, Eleftherios, Nseir, Saadalla, Nseir, William, Odabasi, Zekaver, Papastamopoulos, Vasileios, Paterson, David, Patterson, Thomas F, Peck, Kyong Ran, Peng, Zhiyong, Permpalung, Nitipong, Plantefeve, Gaetan J, Poromanski, Ivan G, Powell, Debra, Psichogiou, Mina, Puah, Ser Hon, Pullman, John, Rahav, Galia, Martinez, Antonio Ramos, Ramos Ramos, Juan Carlos, Raz-Pasteur, Ayelet, Restrepo Castro, Carlos A, Riera, Fernando, Roblot, France, Rodriguez Alvarez, Regino Jose, Rogers, Benjamin, Roilides, Emmanuel, Sanchez Vallejo, Gregorio, Sganga, Gabriele, Sipsas, Nikolaos, Slavin, Monica, Soriano, Alex, Spec, Andrej, Strahilevitz, Jacob, Tancheva, Dora M, Tao, Zhen, Teschner, Daniel, Thompson, George R, Van Wijngaerden, Eric, Vazquez, Jose, Vergidis, Paschalis, Viale, Pierluigi, Wang, Fu-Der, Wang, Shifu, Weber, Gabriel, Weng, Jianyu, Xu, Jinfu, Yao, Li, Yavuz, Serap, Yilmaz, Mesut, Young, Jo-Anne, Zarate, Abel H, Zeng, Jun, Zhang, Yong, Thompson, George R, III ^*, Cornely, Oliver A, Kullberg, Bart Jan, Kollef, Marin, Honore, Patrick M, Bassetti, Matteo, Poromanski, Ivan, Dignani, Cecilia, Das, Anita F, Sandison, Taylor, Pappas, Peter G

Source: In The Lancet 7-13 January 2023 401(10370):49-59

TES and SLC40A1 as Potential Biomarkers for Predicting Survival in T-Cell Acute Lymphoblastic Leukemia.

Authors: Zeng, Xiangyou, Liu, Kaifan, Xu, Ruohao, Zhang, Lenghe, Lai, Peilong, Du, Xin, Weng, Jianyu

Source: Acta Haematologica; Mar2025, Vol. 148 Issue 2, p163-179, 17p

Subject Terms: BIOMARKERS, PROGNOSIS, T cells, RNA sequencing, GENES, GENE expression, SURVIVAL analysis (Biometry)

Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies.

Authors: Ai, Kexin, Liu, Bowen, Chen, Xiaomei, Huang, Chuxin, Yang, liping, Zhang, Weiya, Weng, Jianyu, Du, Xin, Wu, Kongming, Lai, Peilong

Source: Journal of Hematology & Oncology; 11/5/2024, Vol. 17 Issue 1, p1-29, 29p

Subject Terms: CELLULAR therapy, TECHNOLOGICAL innovations, CHIMERIC antigen receptors, CYTOTOXINS, SUBSET selection

Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response

Authors: Guo, Liyan, Lai, Peilong, Wang, Yulian, Huang, Tian, Chen, Xiaomei, Geng, Suxia, Huang, Xin, Luo, Chenwei, Wu, Suijing, Ling, Wei, Huang, Lisi, Du, Xin, Weng, Jianyu

Source: In International Immunopharmacology July 2020 84

Extracellular vesicles from mesenchymal stem cells prevent contact hypersensitivity through the suppression of Tc1 and Th1 cells and expansion of regulatory T cells

Authors: Guo, Liyan, Lai, Peilong, Wang, Yulian, Huang, Tian, Chen, Xiaomei, Luo, Chenwei, Geng, Suxia, Huang, Xin, Wu, Suijing, Ling, Wei, Huang, Lisi, Du, Xin, Weng, Jianyu

Source: In International Immunopharmacology September 2019 74

Attention-guided polarization image fusion based on guided filtering

Authors: Chen, Hongwei, Wang, Xingjun, Liu, Dechao, Cao, Xiaoyu, Weng, Jianyu, Liu, Wei, Lei, Bing

Source: Proceedings of SPIE; December 2024, Vol. 13502 Issue: 1 p135020C-135020C-6, 1215187p

Design and Calibration of a High-Accuracy Polarized Compass Based on Vortex Retarder

Authors: Cao, Xiaoyu, Gao, Chao, Weng, Jianyu, Huang, Yabo, Liu, Wei, Lei, Bing

Source: IEEE Sensors Journal; November 2024, Vol. 24 Issue: 21 p34281-34289, 9p

Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cells

Authors: Geng, Suxia, Yao, Han, Weng, Jianyu, Tong, Jiaqi, Huang, Xin, Wu, Ping, Deng, Chengxin, Li, Minming, Lu, Zesheng, Du, Xin

Source: In Leukemia Research May 2016 44:17-24

The hENT1 and DCK genes underlie the decitabine response in patients with myelodysplastic syndrome

Authors: Wu, Ping, Geng, Suxia, Weng, Jianyu, Deng, Chengxin, Lu, Zesheng, Luo, Chengwei, Du, Xin

Source: In Leukemia Research February 2015 39(2):216-220

Correction: Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells.

Authors: Qin, Le, Lai, Yunxin, Zhao, Ruocong, Wei, Xinru, Weng, Jianyu, Lai, Peilong, Li, Baiheng, Lin, Simiao, Wang, Suna, Wu, Qiting, Liang, Qiubin, Li, Yangqiu, Zhang, Xuchao, Wu, Yilong, Liu, Pentao, Yao, Yao, Pei, Duanqing, Du, Xin, Li, Peng

Source: Journal of Hematology & Oncology; 2/24/2025, Vol. 18 Issue 1, p1-2, 2p

Subject Terms: CHIMERIC antigen receptors, T cells, FLOW cytometry, GENE transfection, HEMATOLOGY

Outcomes of intermediate or high‐risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience.

Authors: Li, Chao, Deng, ChengXin, Wu, Ping, Liu, KaiFan, Huang, Xin, Li, MingMin, Chen, XiaoMei, Geng, SuXia, Lai, PeiLong, Weng, JianYu, Du, Xin

Source: CTS: Clinical & Translational Science; Jan2024, Vol. 17 Issue 1, p1-11, 11p

Subject Terms: VENETOCLAX, CHRONIC leukemia, OVERALL survival

Diagnostic and prognostic value of ferroptosis-related genes in patients with Myelodysplastic neoplasms.

Authors: Chen, Xiaomei, Li, Chao, Wang, Yulian, Geng, Suxia, Xiao, Maozhi, Zeng, Lingji, Deng, Chengxin, Li, Minming, Huang, Xin, Weng, Jianyu, Du, Xin, Lai, Peilong

Source: Hematology; Dec2023, Vol. 28 Issue 1, p1-15, 15p

Subject Terms: GENE ontology, REVERSE transcriptase polymerase chain reaction, PROGNOSIS, GENE expression, DISEASE risk factors

Outcomes in Patients with Chronic Myeloid Leukemia in the Chronic Phase Randomized to Dasatinib or Imatinib after Suboptimal Responses to 3 Months of Imatinib Therapy: Final 5-Year Results from DASCERN

Authors: Cortes, Jorge E., Jiang, Qian ^*, Wang, Jianxiang, Weng, Jianyu, Zhu, Huanling ^*, Liu, Xiaoli ^*, Hochhaus, Andreas, Kim, Dong-Wook, Radich, Jerald ^*, Savona, Michael R., Martin-Regueira, Patricia ^*, Sy, Oumar ^*, Saglio, Giuseppe

Source: In Blood 15 November 2022 140 Supplement 1:9647-9649

A Predictive Scoring System for Therapy Failure in Persons with Chronic Myeloid Leukemia Receiving Initial a Second-Generation Tyrosine Kinase Inhibitor Therapy

Authors: Zhang, Xiaoshuai ^*, Liu, Bingcheng ^*, Huang, Jian ^*, Zhang, Gongli ^*, Liu, Xiaoli ^*, Xu, Na ^*, Li, Weiming ^*, Du, Xin ^*, Weng, Jianyu, Lin, Hai ^*, Liang, Rong ^*, Chen, Chunyan ^*, Zhu, Huanling ^*, Pan, Ling ^*, Yang, Yun-fan ^*, WANG, Xiaodong ^*, Li, Guohui ^*, Liu, Zhuogang ^*, Liu, Zhenfang ^*, Hu, Jianda, Liu, Chunshui ^*, Fei, Li, Yang, Wei ^*, Meng, Li ^*, Gale, Robert Peter, Huang, Xiao Jun, Jiang, Qian ^*

Source: In Blood 15 November 2022 140 Supplement 1:9637-9639

Validation and Use of Predictive Scoring Systems for Molecular Responses in 5,203 Persons with Chronic Myeloid Leukemia

Authors: Zhang, Xiaoshuai ^*, Liu, Bingcheng ^*, Huang, Jian ^*, Zhang, Gongli ^*, Liu, Xiaoli ^*, Xu, Na ^*, Li, Weiming ^*, Du, Xin ^*, Weng, Jianyu, Lin, Hai ^*, Liang, Rong ^*, Chen, Chunyan ^*, Zhu, Huanling ^*, Pan, Ling ^*, Yang, Yunfan ^*, WANG, Xiaodong ^*, Li, Guohui ^*, Liu, Zhuogang ^*, Liu, Zhenfang ^*, Hu, Jianda, Liu, Chunshui ^*, Fei, Li, Yang, Wei ^*, Meng, Li ^*, Gale, Robert Peter, Huang, Xiao Jun, Jiang, Qian ^*

Source: In Blood 15 November 2022 140 Supplement 1:9620-9623

Subjects with Chronic Myeloid Leukemia Identified As Intermediate- or High-Risk Subjects Using the Imatinib Therapy Failure (IMTF) Model Benefit from Initial Therapy with a Second-Generation Tyrosine Kinase Inhibitor

Authors: Zhang, Xiaoshuai ^*, Liu, Bingcheng ^*, Huang, Jian ^*, Zhang, Gongli ^*, Liu, Xiaoli ^*, Xu, Na ^*, Li, Weiming ^*, Du, Xin ^*, Weng, Jianyu, Lin, Hai ^*, Liang, Rong ^*, Chen, Chunyan ^*, Zhu, Huanling ^*, Pan, Ling ^*, Yang, Yun-fan ^*, WANG, Xiaodong ^*, Li, Guohui ^*, Liu, Zhuogang ^*, Liu, Zhenfang ^*, Hu, Jianda, Liu, Chunshui ^*, Fei, Li, Yang, Wei ^*, Meng, Li ^*, Gale, Robert Peter, Huang, Xiao Jun, Jiang, Qian ^*

Source: In Blood 15 November 2022 140 Supplement 1:3891-3894

Is the 2nd Generation Tyrosine Kinase-Inhibitor a Better Initial Therapy Than Imatinib in Persons with Chronic Myeloid Leukemia Presenting in Accelerated Phase: A Multicenter Retrospective Study

Authors: Yang, Sen ^*, Zhang, Xiaoshuai ^*, Zhang, Yanli ^*, Du, Xin ^*, Weng, Jianyu, Zhu, Huanling ^*, Pan, Ling ^*, Yang, Yun-fan ^*, Meng, Li ^*, Liu, Zhenfang ^*, Liu, Xiaoli ^*, Xu, Na ^*, Chen, Chunyan ^*, WANG, Xiaodong ^*, Liang, Rong ^*, Huang, Jian ^*, Li, Guohui ^*, Liu, Chunshui ^*, Lin, Hai ^*, Hu, Jianda, Fei, Li, Liu, Bingcheng ^*, Li, Weiming ^*, Liu, Zhuogang ^*, Yang, Wei ^*, Huang, Xiao Jun, Jiang, Qian ^*

Source: In Blood 15 November 2022 140 Supplement 1:815-817